Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$3.00 - $4.00
Shares Offered
3,333,334
Deal Size
$11.67M
APUS Statistics
Total Valuation
APUS has a market cap or net worth of $40.33 million. The enterprise value is $40.67 million.
Market Cap | 40.33M |
Enterprise Value | 40.67M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
APUS has 11.52 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 11.52M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -22.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$711,411 |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.36M |
Pretax Income | -1.42M |
Net Income | -1.42M |
EBITDA | -1.36M |
EBIT | -1.36M |
Earnings Per Share (EPS) | -$0.12 |
Balance Sheet
The company has $63,326 in cash and $399,462 in debt, giving a net cash position of -$336,136 or -$0.03 per share.
Cash & Cash Equivalents | 63,326 |
Total Debt | 399,462 |
Net Cash | -336,136 |
Net Cash Per Share | -$0.03 |
Equity (Book Value) | -713,965 |
Book Value Per Share | -0.06 |
Working Capital | -414,503 |
Cash Flow
Operating Cash Flow | -1.06M |
Capital Expenditures | n/a |
Free Cash Flow | -1.06M |
FCF Per Share | -$0.09 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
APUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.53% |
FCF Yield | -2.63% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |